- cafead   Jan 31, 2024 at 12:12: PM
via Even with a competitor’s drug now on the scene, Novo Nordisk is aiming for another year of dominance in the obesity arena thanks in large part to a resupply of starter doses of the company’s weight-loss blockbuster Wegovy.
article source
article source